We have previously demonstrated that tumor models, which more accurately represent the modest five-fold CXCR4 over-expression found in the clinical situation, such as the MIN-O model used in this study, better represent the clinically found CXCR4 expression levels in tumors [17]. This evidence concerns the gene CXCR4 and neoplasm.